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ABSTRACT
Background and objectives: Timely diagnosis of leptospirosis is essential for an effective treatment. Large diversity of 
clinical symptoms has led leptospirosis diagnosis difficult. Researchers have conducted many tests with wide-range of 
sensitivity and specificity to achieve novel diagnostic procedures which have higher sensitivity and specificity compared 
with previous tests and which are more reliable and available to public laboratories. This study aimed to introduce Lsa63 
and LipL32 proteins-based ELISA tests with more sensitivity, specificity, accuracy and convenience for public laboratories.
Materials and Methods: Recombinant forms of Lsa63 and LipL32 proteins were first generated. After coating these 
proteins, IgM and IgG ELISA tests were performed. 220 patients with suspicion of leptospirosis infection were selected for 
serum collection. The sera tests were carried out using MAT, IgM and IgG ELISA tests. In order to assess the performance 
of ELISA, the results of this test were compared with MAT. 
Results: 30% of serum samples (n=65) in MAT were positive for leptospirosis infection, while ELISA tests including 
rLipL32- rLsa63-IgM and rLipL32-rLsa63-IgG showed 40.45% (n=89) and 38.63% (n=80) positive reaction respectively.
Conclusion: Our results demonstrated that new ELISA tests based on mixing LipL32 and Lsa63 proteins, a novel mixture of 
recombinant antigens, are valuable to detect specific antibodies against pathogenic Leptospira in human serum and could be 
considered as helpful techniques in leptospirosis diagnosis.
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INTRODUCTION
Leptospirosis is known as a zoonotic infection 
throughout the world. Humans always acquire 
leptospirosis through a direct or an indirect contact with 
infected animals, soil and surface water contaminated 
with Leptospira excreted from animals’ urine (1-3). 
Clinical manifestations of leptospirosis vary from 
mild to severe. Fever, myalgia, headache, malaise, 
intense jaundice and bleeding are its main symptoms. 
The severest form of this infection named Weil’s 
disease, causes pulmonary hemorrhage syndrome 
and liver or renal failure and consequently results in 
death. The major concern with leptospirosis is the 
large diversity of clinical symptoms which makes 
the diagnosis difficult and requires various laboratory 
tests (4-6). At the present time, techniques commonly 
used in laboratories for leptospirosis diagnosis are 
bacteriological  culture (bacterial culture seems 
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leptolab.ut.ac.ir). These serovars are predominantly 
present in Guilan provinces of Iran where we collected 
our samples (14). These bacteria were maintained 
throughout the study for MAT performance. The 
MAT was done according to standard method using 
the panel of six references Leptospira interrogans 
serovars mentioned above (15). The 6 live Leptospira 
serovars were cultured in Ellinghausen-McCullough-
Johnson-Harris (EMJH) media for performing MAT 
on patient’s sera. Serum specimens serially diluted 
in 96 well microtiter plates (flat bottomed) and then 
suspended live Leptospira cells were added to each 
well. The plates were examined for microagglutination 
reaction by dark field microscope after two hours 
incubation at 37°C. The reactions with maximum 
dilution of serum that agglutinated at least 50% of the 
cells for each serovars were marked as positive. Titer 
of each serum was measured. A positive MAT was 
considered at titer of ≥100 for single samples. 
LipL32 and Lsa63 genes were amplified from the 
genomic DNA of L. interrogans serovar Copenhageni 
by PCR with specific primers without the signal 
peptides (Table 1). The primers were designed by 
clontech software. (http://www.clontech.com/US/
Products/Cloning_and_Competent_Cells/Selection_
Guides/Online_In-Fusion_Tools)
The derived amplicons from each gene that encodes 
LipL32 and Lsa63 were cloned directly into pET28a 
(+) vector at NdeI and XhoI restriction sites by 
Clontech cloning kit (Clontech, USA). The inserted 
DNA combined with 6His tag at the 5′ end. The 
accuracy of cloning was verified by DNA sequencing 
of recombinant plasmids. The recombinant plasmids 
of each gene were then transformed into E. coli BL-
21 (DE3) strain as expressing host. A single colony of 
E. coli BL21 (DE3) containing recombinant plasmids 
pET28a (+)-LipL32 or pET28a (+)-Lsa63 were 
selected and grown at 37°C on 5 ml Luria-Bertani 
broth (LB) containing kanamycin for overnight to 
inoculate 500 ml of LB broth containing kanamycin. 
to be a better choice), microscopic agglutination 
test (MAT), serological tests (ELISA, IFA and 
agglutination based tests) and molecular tests such as 
PCR-based tests (2-3). These methods have several 
problems for a specific and sensitive leptospirosis 
diagnosis. The inconclusiveness of previous tests 
has led researchers to develop more definitive tests 
with higher sensitivity and specificity which could be 
readily available to public laboratories (6-8).
In this study we investigated two Leptospira 
antigens (Lsa63 and LipL32) which have been 
previously identified as adhesion proteins in the 
surface of pathogenic Leptospira serovars. These two 
antigens were selected as new serological markers (9-
13). The aims of this study were to develop ELISA 
tests using recombinant Lsa63 antigen mixed with 
recombinant LipL32 antigen and to offer new tests for 
exploring the potential of these antigens in diagnosis 
of leptospirosis. This is the first study conducted to 
develop new ELISA tests based on the use of novel 
antigens for serodiagnosis of human leptospirosis. We 
produced the recombinant form of Lsa63 and Lipl32 
antigens and developed two ELISA tests based on 
this novel mixture of antigens. 
MATERIALS AND METHODS
Serum samples (n=220) were obtained from 
patients suspected of leptospirosis. The patients 
had jaundice, fever, headache, nausea and myalgia 
symptoms during their visits to local hospitals 
(Guilan University of Medical Sciences hospitals). 
The sera were divided into three aliquot parts and 
stored at -20°C until analysis. All serum samples 
were tested by MAT method as a golden test for 
serodiagnosis of leptospirosis.  
Leptospira interrogans serovars namely Grippotyphosa, 
Pomona, Icterohaemorrhagiae, Canicola, Hardjo and 
Ballum were obtained from Leptospira Research 
Laboratory of Tehran University (http://www.
Table 1. The designed primers for amplifying LipL32 and Lsa63 protein genes by PCR.
Name Primer sequence Restriction enzyme site
LipL32-F 5′- CGCGCGGCAGCCATATGTGTGGTGCTTTCGGTGGTC -3′ NdeI
LipL32-R 5′- GGTGGTGGTGCTCGAGCTTAGTCGCGTCAGAAGCAG -3′ XhoI
Lsa63-F 5′- CGCGCGGCAGCCATATGGAAAGTTCTAAACTCGGAG -3′ NdeI
Lsa63-R 5′- GGTGGTGGTGCTCGAGAATCAGTTTTAGATCGGC -3′ XhoI
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These two recombinant clones were induced by 
isopropyl-D-thiogalactopyranoside (IPTG) in a 
final concentration of 1mM. After five hours of 
induction, the bacterial cell pellet was harvested by 
centrifugation at 12000 rpm for 15 min and gently 
lysed by ultrasonication. The expressed proteins 
were analyzed by 12% Sodium Dodecyl Sulfate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
and then measured by using Bradford biochemical 
method. Lysate of each protein was loaded into a Ni-
NTA column [Qiagen; USA] to extract the N-terminal 
6His tagged fused recombinant LipL32 and Lsa63 
proteins under native conditions by gradient 
concentration of imidazole ranged from 150 to 350 
mM. The first two ml of purified fractions containing 
the rLipL32 or rLsa63 proteins were collected and 
dialyzed in 0.01M PBS pH 7.2 overnight to remove 
the imidazole. Using SDS-PAGE, purity of extracted 
proteins were determined and then concentrated by 
freeze-dried lyophilizer.
Western blotting was done according to standard 
protocol using the anti-His-tag antibody. The extracted 
rLipL32 and rLsa63 were transferred from the SDS-
PAGE separation gel to a nitrocellulose membrane 
(Dassel, Germany) by Biorad system. The blotting 
membranes were blocked with Phosphate-buffered 
saline (PBS pH 7.5) containing 3% bovine serum 
albumin (BSA) for one hour. The membranes were 
washed five times with PBS containing 0.05% Tween 
20 (PBST). The blocked papers were incubated in a 
suitable dilution of Goat anti-rabbit IgG-Conjugated 
to horseradish peroxidase at 4°C for overnight. 
Finally, these membranes were then washed five 
times with TBST. Diaminobenzidine solution (DAB; 
Sigma, USA) was added to the papers for developing 
reactions. 
A 1:1 dilution mixture of purified rLipL32 and 
rLsa63 was prepared in 0.06 M carbonate bicarbonate 
buffer pH 9.6 at a concentration and diluted to 1 ng/
μl. Each well of an ELISA plate (MaxiSorp, Nunc) 
was loaded with 50 μl per well of the mixture proteins 
and incubated in a humid chamber at 4°C overnight. 
For removing unbound antigens, the coating plates 
were washed four times with 0.05% Tween phosphate 
buffered saline pH 7.4 (PBST) and all wells were 
blocked with 300 μl of 5% skim milk at 37°C for 
two hours. Excess blocking buffer was washed off 
five times with PBST. The best concentration of the 
antigens, antibodies and conjugate were determined 
by checkerboard plates (16). The biggest difference 
between optical density of positive and negative 
samples in ELlSA were obtained by coating 50 
μl (1 ng/μl) of rLipL32 and rLsa63 antigen, 1/50 
dilution of serum and 1/5000 dilution of horse radish 
peroxidase (HRP) conjugate.  Serum samples diluted 
1:50 in diluent buffer (0.2% gelatin + 0.2% BSA in 
PBS) and was loaded 50 μl to ELISA plate wells. 
The plates were incubated at 37°C for one hour. After 
washing the plates, 50 μl anti-Human IgG or IgM 
conjugated to HRP (1:5000) were added to each wells 
as the second antibody to evaluate IgG or IgM level 
against Leptospira spp within sera from leptospirosis 
patients. The plates were washed five more times 
and then added 100 μl TMB substrate solution to the 
wells. Reactions were left to react for 15 minutes at 
room temperature and dark place. Finally, 100 μl stop 
solution (2 M H2SO4) was added to each wells. The 
absorbance value of wells was read using an ELISA 
reader at a wavelength of 405 nm. For determination 
of cut-off value, the mean cut-off point was calculated 
at OD450 + 3SD by obtaining the mean value of OD 
from the ELISA performed on 50 MAT negative 
control sera.
Statistical analysis, With 95% confidence interval, 
the accuracy, sensitivity, specificity and likelihood 
ratios for the ELISAs based on rLipL32 + rLsa63 
were calculated in compared to the MAT assay as a 
golden test. All analyses were done using the user-
written modules Diagt in stata software (release 10; 
StataCorp LP, College station, TX, USA).
RESULTS 
The genes encoding the LipL32 and Lsa63 protein 
were cloned successfully into pET28a(+) expression 
vector by clontech system. The cloned plasmids 
[pET28a (+)-LipL32, pET28a (+)-Lsa63] were 
checked by colony PCR then performed double 
digestion by NdeI and XhoI. The digestion product 
was electrophoresed on 8 g/L agarose gel. The results 
showed that the recombinant plasmid contained the 
expected genes. The results of plasmid sequencing 
proved that the inserted sequences of LipL32 and 
Lsa63 into the vector were correct.
The recombinant clones highly expressed objective 
genes by IPTG and produced rLipL32 or rLsa63 
proteins was purified in native condition. The analysis 
of SDS–PAGE results indicated that 32 kDa and 
63 kDa proteins high expressed clearly which were 
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related to objective proteins. Recombinant LipL32 
and Lsa63 proteins were evaluated by anti-6His tag 
antibody (Sigma, USA) in Western blot which the 
proteins appeared clearly visible bands 32 and 63 
kDa highly expressed those were related to predicted 
proteins. (Fig. 1)
Cut off value for rLipL32-rLsa63-IgM-ELISA 
and rLipL32-rLsa63-IgG-ELISA were measured. 
Obtained Cut-off points were 0.45 and 0.42 for IgM 
and IgG of our ELISAs, respectively
Among 220 serum samples were obtained from 
patients who suspected of having leptospirosis, 65 
(30%) were positive according to the MAT assay 
that considered positive specimens and 155 (70%) 
were negative. The rLipL32-rLsa63-IgM-ELISA 
and rLipL32-rLsa63-IgG-ELISA showed positive 
reaction 40.45% (n=89) and 38.63% (n=80), 
respectively. In compared to MAT, the rLipL32-
rLsa63-IgM-ELISA had a 96.62%, a 83.23%, a 
70.78% and a 98.47% sensitivity, specificity, PPV 
and NPV, respectively, and also rLipL32-rLsa63-
IgG-ELISA had a 92.31%, a 83.87 %, a 70.59% 
and a 96.30% sensitivity, specificity, PPV and NPV, 
respectively. The summarized results have been 
shown in table 2.
DISCUSSION
Until now, the golden test for diagnosis of 
Leptospiral infections is MAT (3-4) but this test is 
not effective during early phases of the illness (2). 
To overcome this problem, different serological tests 
using single Leptospiral recombinant outer membrane 
proteins (OMP) such as Lipl32, LipL21, OmpL1/2, 
Lipl41 and rLoa22 and others have been established 
(6, 10, 17-20) Up to now, many researchers developed 
different ELISAs using the single recombinant 
Leptospiral surface proteins as the antigens (21-22), 
for example; Bomfim developed an ELISA by using 
single recombinant LipL32 for diagnosis of canine 
leptospirosis (9), Senthilkumar established an ELISA 
based on rLipL42 protein for canine leptospirosis 
diagnose and reported a sensitivity of 83.33% and 
specificity of 93.07% for it (16), Srimanote made an 
ELISA tests (IgM and IgG) with recombinant ligA 
(6), Dey developed an ELISA with the recombinant 
fig 1. western blot of rLsa63 and rLipL32 proteins (Left to 
Right: Line 1 LipL32, Line 2 protein size marker, Line 3 Lsa63)
Table 2. Test performances of the LipL32-Lsa63-ELISAs tests, when compared to the MAT
Test performances IgM-Lsa63 ELISA IgG-Lsa63 ELISA
Sensitivity (%) (95% CI) 96.62 (89.46 – 99.15) 92.31  (85.83 – 98.79)
Specificity (%) (95% CI) 83.23  (76.56 – 88.29) 83.87  (78.08 – 89.66)
Positive predictive value (%) (95% CI) 70.78  (60.19-79.9) 70.59  (60.90 – 80.27)
Negative predictive value (%) (95% CI) 98.47  (94.59- 99.81) 96.30  (93.11 – 99.48)
Positive likelihood ratio (95% CI) 5.778  (4.058 - 8.227) 5.723  (3.97 – 8.25)
Negative likelihood ratio      (95%  CI) 0.037  (0.009 - 0.145) 0.0917  (0.0394 – 0.2135)
Test accuracy (%) (95% CI) 87.27  (82.87 – 91.68) 86.36  (81.83 – 90.90)
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LipL32 antigen for detection of anti-Leptospiral 
antibodies in human serum samples and reported an 
acceptable sensitivity and specificity for their tests 
(23), Oliveira developed ELISA based on MPL17 
and MPL21 antigens that have specificity 95.5% and 
80.6%, respectively (19). 
Nevertheless, these tests cannot convince scientists 
to use them in public laboratory because the accuracy, 
sensitivity and specificity are not suitable. Therefore 
researchers studied new recombinant antigens for 
establishing new tests. Several reports demonstrated 
that use of more antigens have been improving the 
accuracy of immunoassay tests (19, 24-25). Sun 
have developed ELISA tests by using three antigens 
including rLipL32/1, LipL21 and OmpL1/2 in fusion 
form. They reported the IgM ELISA based on this 
fusion antigen with 93.1% positive result (25).
In the present study, we established ELISAs with the 
novel combination of two Leptospiral recombinant 
surface antigens (rLipL32 and rLsa63). The antigens 
were previously proved to react with serum from 
patient’s suspected Leptospira infections. LipL32 is 
the most present antigen on the surface of Leptospira 
and is highly common among pathogenic Leptospira 
strains (9, 11). This protein is highly expressed during 
leptospirosis and recognized through the humoral 
immune reaction in patients (11-12, 25). Furthermore, 
previous study by Vieira also demonstrated that Lsa63 
protein appears on surface of pathogenic Leptospira 
acts as an adhesion (13). 
The immune system will recognize cell surface 
antigens while initial contact of pathogenic Leptospira 
occur, and produce antibodies against them. Since the 
antibodies generated against the surface antigens of 
the bacteria, recombinant form of these antigens may 
supply the best candidates for establishing diagnostic 
tests (18). These studies demonstrated that LipL32 
and Lsa63 are unique to pathogenic Leptospires and 
that the antibodies related to these antigens were 
detected exclusively in Leptospira infected host sera 
(9, 11-13). These facts suggested that a mixture of 
recombinant form of LipL32 and Lsa63 antigens 
may be suitable to identify Leptospiral infection. 
Our special interest was to explore potential of 
LipL32 + Lsa63 mixture as an antigen in diagnosis 
of leptospirosis. 
  To our knowledge, this is a novel mixture that 
is used to develop ELISA tests for diagnosis of 
human leptospirosis with a defined set of sensitivity, 
specificity and accuracy in comparison to MAT 
as golden test. For this purpose, two ELISAs tests 
were generated by using the mixture for detection 
of specific IgM and IgG antibodies for pathogenic 
Leptospira serovars and then the serum samples 
assayed by them. 
Our results showed that the rLipL32+Lsa63-IgM-
ELISA and rLipL32+Lsa63-IgG-ELISA had high 
sensitivity (96.62% and 92.31% for 1:50 dilutions, 
respectively) recognizing specific antibodies 
directed to Leptospiral antigens. In contrast MAT 
using 65 human sera showed MAT titers ≥100 
when the six serovars were tested. In this study, 
specificity of rLipL32+Lsa63-IgM-ELISA was 
83.23 % and rLipL32+Lsa63-IgG-ELISA was 
83.87% in comparative to the MAT when 155 MAT-
negative sera were used. Our findings indicated that 
rLipL32+rLsa63 mixture is very immunogenic and 
when they are used together as a coated antigen could 
efficiently raise the detection accuracy, sensitivity and 
specificity and could thus be useful tool to develop a 
confirmative serological test. 
Although we found that the LipL32 + Lsa63-
ELISAs show good accuracy, specificity and 
sensitivity for diagnosis of human leptospirosis, but 
more confirmation of the tests in other populations 
from another area with other serovars prevalence is 
needed to validate of the present findings. Then there 
is a necessity for additional studies with a greater 
number of different patient sera from different region 
to evaluate its accuracy and making it a practical test 
for development of a serological kit for diagnosing of 
Leptospiral infections.
In conclusion, our findings suggested that (rLsa63 + 
rLipL32)-ELISAs is a specific, sensitive and practical 
test for the detection of specific antibodies against 
pathogenic Leptospira. In addition, the results of our 
ELISAs were obtained using a single sample (1/50 
diluted serum), we suggest future studies use more 
recombinant antigens and also obtaining two serum 
samples each one or two weeks apart could further 
help to validate our results.
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